[On the surgical therapy of basaliomata and carcinomata of the facial skin].
Following surgical therapy, skin carcinomata as well as basaliomata require strict aftercare. Most careful attention should be given especially to dedifferentiated, nonkeratinizing squamous cell carcinomata that usually show a higher rate of relapsing and metastasizing. (2) The relatively high rate of metastasizing of 10 to 20%, which is evident from the literature and could be confirmed by the author for his own patient stock, requires uncompromising removal of the dependent lymphatic region in the form indicated for tumors with the formula T1 N1-2 Mo, T2-3 No Mo, for relapsing carcinomata, and for histologically evident nonkeratinizing squamous cell carcinomata. Only very old age or a poor general condition admit of exceptions to be made.
D000368:Aged; D002277:Carcinoma / Q000601:surgery*; D002280:Basal Cell Carcinoma / Q000601:surgery*; D005153:Facial Neoplasms / Q000601:surgery*; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D012878:Skin Neoplasms / Q000601:surgery*
Zur chirurgischen Therapie der Basaliome und Karzinome der Gesichtshaut.